Name: Tata India Pharma & HealthCare Fund Regular Growth
Brand: Tata Mutual Fund

Home>Mutual Funds>Tata Mutual Fund>Tata India Pharma & HealthCare Fund Regular Growth

bookmark_border
share
Tata India Pharma & HealthCare Fund Regular Growth
Equity
Sectoral / Thematic
Very High Risk
25.35%
3Y annualised
-1.06% 1D
1M
6M
1Y
3Y
5Y
All
 NAV: 20 Oct 2021₹17.48
Min. SIP amountNA
Rating1star
Fund size₹590.03 Cr
Understand termsAnnualised returnsAverage of the yearly returns of a mutual fund over a given period.
Absolute returnsThe total return of a mutual fund over a given period.
Returns and rankingsCategory: Equity Sectoral / Thematic
Annualised returns
Absolute returns
1Y3Y5YAll
Fund returns29.0%25.4%12.9%10.1%
Category average58.4%28.2%13.5%NA
Rank with in category732NA
Understand termsinfo
Holdings (29)NameSectorInstrumentAssets
Sun Pharmaceutical Industries Ltd.
HealthcareEquity12.0%
Dr. Reddy's Laboratories Ltd.
HealthcareEquity8.6%
Divi's Laboratories Ltd.
HealthcareEquity8.5%
Cipla Ltd.
HealthcareEquity8.3%
Alkem Laboratories Ltd.
HealthcareEquity7.0%
Ipca Laboratories Ltd.
HealthcareEquity6.5%
Apollo Hospitals Enterprise Ltd.
HealthcareEquity6.4%
Narayana Hrudayalaya Ltd.
HealthcareEquity4.7%
Lupin Ltd.
HealthcareEquity3.6%
Fortis Healthcare Ltd.
HealthcareEquity3.5%
See All
Understand termsExpense ratioA fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
TaxA percentage of your capital gains payable to the government upon exiting your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
Exit loadA fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
Stamp dutyA form of tax payable for the purchase or sale of an asset or security. 
Past expense ratio & exit load
Expense ratio
Exit load
31 Aug 2021 - Present
2.69%
31 Jul 2021 - 31 Aug 2021
2.57%
30 Jun 2021 - 31 Jul 2021
2.61%
31 May 2021 - 30 Jun 2021
2.64%
30 Apr 2021 - 31 May 2021
2.61%
31 Mar 2021 - 30 Apr 2021
2.55%
28 Feb 2021 - 31 Mar 2021
2.63%
31 Jan 2021 - 28 Feb 2021
2.64%
31 Dec 2020 - 31 Jan 2021
2.63%
30 Nov 2020 - 31 Dec 2020
2.64%
31 Oct 2020 - 30 Nov 2020
2.64%
30 Sep 2020 - 31 Oct 2020
2.66%
31 Aug 2020 - 30 Sep 2020
2.65%
31 Jul 2020 - 31 Aug 2020
2.63%
30 Jun 2020 - 31 Jul 2020
2.41%
31 May 2020 - 30 Jun 2020
2.64%
30 Apr 2020 - 31 May 2020
2.60%
31 Mar 2020 - 30 Apr 2020
2.74%
29 Feb 2020 - 31 Mar 2020
2.54%
31 Jan 2020 - 29 Feb 2020
2.55%
31 Dec 2019 - 31 Jan 2020
2.31%
30 Nov 2019 - 31 Dec 2019
2.58%
31 Oct 2019 - 30 Nov 2019
2.58%
30 Sep 2019 - 31 Oct 2019
2.58%
31 Aug 2019 - 30 Sep 2019
2.55%
31 Jul 2019 - 31 Aug 2019
2.55%
30 Jun 2019 - 31 Jul 2019
2.55%
31 May 2019 - 30 Jun 2019
2.56%
30 Apr 2019 - 31 May 2019
2.74%
31 Mar 2019 - 30 Apr 2019
2.86%
28 Feb 2019 - 31 Mar 2019
2.82%
31 Jan 2019 - 28 Feb 2019
2.79%
31 Dec 2018 - 31 Jan 2019
2.79%
30 Nov 2018 - 31 Dec 2018
2.89%
31 Oct 2018 - 30 Nov 2018
2.87%
30 Sep 2018 - 31 Oct 2018
2.84%
31 Aug 2018 - 30 Sep 2018
2.90%
31 Jul 2018 - 31 Aug 2018
2.78%
30 Jun 2018 - 31 Jul 2018
2.96%
31 May 2018 - 30 Jun 2018
2.88%
30 Apr 2018 - 31 May 2018
2.84%
31 Mar 2018 - 30 Apr 2018
2.94%
28 Feb 2018 - 31 Mar 2018
1.40%
31 Jan 2018 - 28 Feb 2018
2.68%
31 Dec 2017 - 31 Jan 2018
2.91%
30 Nov 2017 - 31 Dec 2017
2.91%
31 Oct 2017 - 30 Nov 2017
2.91%
Expense ratio, exit load and taxExpense ratio: 2.69%Inclusive of GST
Exit loadExit load of 0.25% if redeemed within 30 days.
Stamp duty0.005% (from July 1st, 2020)
Tax implicationReturns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year. 
Understand termsinfo
Check past data
Minimum investment amountsMin. for 1st investmentNA
Min. for 2nd investment onwardsNA
Min. for SIPNA
Fund managementSailesh Jain
Nov 2018 - Present
View details
keyboard_arrow_down
Education
Mr. Jain is a Commerce Graduate and an MBA.
Experience
Prior to joining TATA Mutual Fund, he has worked with Invesco Mutual Fund, IDFC Securities Ltd. as Head Derivatives, Quant Broking Pvt Ltd. as Vice President and IIFL(India Infoline) as Vice President.
Also manages these schemes
Tata Equity Savings Fund Regular IDCW Monthly
Tata Equity Savings Fund Regular Growth
Tata Equity Savings Fund Regular IDCW
Tata Equity Savings Fund Direct IDCW Monthly
Tata Equity Savings Fund Direct IDCW
Tata Equity Savings Fund Direct Growth
Tata Digital India Fund Direct IDCW
Tata Digital India Fund Regular IDCW
Tata Digital India Fund Regular Growth
Tata Digital India Fund Direct Growth
Tata India Pharma & HealthCare Fund Direct IDCW
Tata India Pharma & HealthCare Fund Regular IDCW
Tata India Pharma & HealthCare Fund Direct Growth
Tata India Pharma & HealthCare Fund Regular Growth
Tata Resources & Energy Fund Direct Growth
Tata Resources & Energy Fund Regular IDCW
Tata Resources & Energy Fund Regular Growth
Tata Resources & Energy Fund Direct IDCW
Tata Arbitrage Fund Regular Growth
Tata Arbitrage Fund Direct Growth
Tata Nifty Exchange Traded Fund Growth
Tata Balanced Advantage Fund Regular Growth
Tata Balanced Advantage Fund Direct Growth
Tata Nifty Private Bank Exchange Traded Fund Growth
Tata Quant Fund Direct Growth
Tata Quant Fund Regular Growth
Tata Quant Fund Regular IDCW
Tata Quant Fund Direct IDCW
Tata Multi Asset Opportunities Fund Direct IDCW
Tata Multi Asset Opportunities Fund Regular Growth
Tata Multi Asset Opportunities Fund Direct Growth
Tata Dividend Yield Fund Direct Growth
Tata Dividend Yield Fund Regular Growth
Rahul Singh
Apr 2020 - Present
View details
keyboard_arrow_down
Education
Mr. Singh is B.Tech & PGDBM
Experience
Prior to Tata AMC, he has worked with Ampersand Capital Investment Advisors LLP, Standard Chartered Securities and Citigroup Global Markets India.
Also manages these schemes
Tata Young Citizens Regular
Tata Digital India Fund Direct IDCW
Tata Digital India Fund Regular IDCW
Tata Digital India Fund Regular Growth
Tata Digital India Fund Direct Growth
Tata India Pharma & HealthCare Fund Direct IDCW
Tata India Pharma & HealthCare Fund Regular IDCW
Tata India Pharma & HealthCare Fund Direct Growth
Tata India Pharma & HealthCare Fund Regular Growth
Tata Resources & Energy Fund Direct Growth
Tata Resources & Energy Fund Regular IDCW
Tata Resources & Energy Fund Regular Growth
Tata Resources & Energy Fund Direct IDCW
Tata Balanced Advantage Fund Regular Growth
Tata Balanced Advantage Fund Direct Growth
Tata Focused Equity Fund Direct Growth
Tata Focused Equity Fund Direct IDCW
Tata Focused Equity Fund Regular Growth
Tata Focused Equity Fund Regular IDCW
Tata Multi Asset Opportunities Fund Direct IDCW
Tata Multi Asset Opportunities Fund Regular Growth
Tata Multi Asset Opportunities Fund Direct Growth
Tata Dividend Yield Fund Direct Growth
Tata Dividend Yield Fund Regular Growth
Meeta Shetty
Nov 2018 - Present
View details
keyboard_arrow_down
Education
Ms. Shetty is Bachelor in Economics and CFA Charterholder
Experience
Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
Also manages these schemes
Tata Large & Mid Cap Fund Regular IDCW
Tata Large & Mid Cap Fund Regular Growth
Tata Large & Mid Cap Fund Direct Plan IDCW
Tata Large & Mid Cap Fund Direct Plan Growth
Tata Digital India Fund Direct IDCW
Tata Digital India Fund Regular IDCW
Tata Digital India Fund Regular Growth
Tata Digital India Fund Direct Growth
Tata India Pharma & HealthCare Fund Direct IDCW
Tata India Pharma & HealthCare Fund Regular IDCW
Tata India Pharma & HealthCare Fund Direct Growth
Tata India Pharma & HealthCare Fund Regular Growth
Fund house & investment objective
keyboard_arrow_down
Tata Mutual Fund
Rank (total assets)#14 in India
Total AUM61,612.23 Cr
Date of Incorporation30 Jun 1995
Tata India Pharma & HealthCare Fund Regular Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to inve
Tata India Pharma & HealthCare Fund Regular Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 30 Jun 1995. Rupesh Patel, Sonam Udasi is the Current Fund Manager of Tata India Pharma & HealthCare Fund Regular Growth fund. The fund currently has an Asset Under Management(AUM) of ₹61,612 Cr and the Latest NAV as of 20 Oct 2021 is ₹17.48.
The Tata India Pharma & HealthCare Fund Regular Growth is rated Very High risk. Minimum SIP Investment is set to 500. Exit load of 0.25% if redeemed within 30 days....Read more
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in t
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
...Read more
Fund benchmarkNIFTY Pharma TRI
descriptionScheme Information Document(SID)
Fund house contact details
keyboard_arrow_down
Address
Mafatlal Centre, 9th Floor, Nariman Point Mumbai 400021
Phone
022 6657 8282
Launch Date
30 Jun 1995
E-mail
[email protected]
Website
NA
Tata Mutual Fund
Asset Management Company
Custodian
Standard Chartered Bank
Registrar & Transfer Agent
Cams
Address
7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
Email
[email protected]
Website
www.camsonline.com
Compare funds
Tata India Pharma & HealthCare Fund Regular Growth
VS
Add mutual fund to compare

No.11, 2nd floor, 80 FT Road
4th Block, S.T Bed, Koramangala
Bengaluru – 560034
Contact Us
PRODUCTS
StocksFutures & OptionsMutual FundsFixed DepositUS Stocks
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemap
ⓒ 2016-2021 Groww. All rights reserved, Built with ♥in India

	1Y	3Y	5Y	All
Fund returns	29.0%	25.4%	12.9%	10.1%
Category average	58.4%	28.2%	13.5%	NA
Rank with in category	7	3	2	NA

Name	Sector	Instrument	Assets
Sun Pharmaceutical Industries Ltd.	Healthcare	Equity	12.0%
Dr. Reddy's Laboratories Ltd.	Healthcare	Equity	8.6%
Divi's Laboratories Ltd.	Healthcare	Equity	8.5%
Cipla Ltd.	Healthcare	Equity	8.3%
Alkem Laboratories Ltd.	Healthcare	Equity	7.0%
Ipca Laboratories Ltd.	Healthcare	Equity	6.5%
Apollo Hospitals Enterprise Ltd.	Healthcare	Equity	6.4%
Narayana Hrudayalaya Ltd.	Healthcare	Equity	4.7%
Lupin Ltd.	Healthcare	Equity	3.6%
Fortis Healthcare Ltd.	Healthcare	Equity	3.5%

Rating	1
Fund size	₹590.03 Cr

Rank (total assets)	#14 in India
Total AUM	61,612.23 Cr